{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:33:49Z","timestamp":1762868029850},"reference-count":30,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Staphylococcus aureus<\/jats:italic>isolates which produce type A staphylococcal \u03b2-lactamase have been associated with wound infections complicating the use of cefazolin prophylaxis in surgery. To further evaluate this finding, 215 wound isolates from 14 cities in the United States were characterized by antimicrobial susceptibility and \u03b2-lactamase type and correlated with the preoperative prophylactic regimen. Borderline-susceptible<jats:italic>S. aureus<\/jats:italic>isolates of phage group 5 (BSSA-5), which produce large amounts of type A \u03b2-lactamase and exhibit borderline susceptibility to oxacillin, comprised a greater percentage of the 120 wound isolates associated with cefazolin prophylaxis than they did of the 95 isolates associated with other prophylactic regimens (25% versus 12.6%, respectively;<jats:italic>P<\/jats:italic>&lt; 0.05). In contrast, methicillin-resistant<jats:italic>S. aureus<\/jats:italic>isolates were distributed evenly between the two groups (8.3% versus 11.6%, respectively). In vitro assays demonstrated that cefazolin was hydrolyzed faster by BSSA-5 strains than by other \u03b2-lactamase-producing, methicillin-susceptible strains (1.54 versus 0.50 \u03bcg\/min\/10<jats:sup>8<\/jats:sup>CFU, respectively;<jats:italic>P<\/jats:italic>&lt; 0.0001). These data demonstrate that BSSA-5 strains are a distinct subpopulation of methicillin-susceptible<jats:italic>S. aureus<\/jats:italic>which frequently cause deep surgical wound infections. Cefazolin use in prophylaxis is a risk factor for BSSA-5 infection.<\/jats:p>","DOI":"10.1128\/jcm.36.1.219-222.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:22:48Z","timestamp":1577812968000},"page":"219-222","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Association of Borderline Oxacillin-Susceptible Strains of<i>Staphylococcus aureus<\/i>with Surgical Wound Infections"],"prefix":"10.1128","volume":"36","author":[{"given":"Douglas S.","family":"Kernodle","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Department of Medicine,1 and"},{"name":"<!--label omitted: 2-->Department of Veterans Affairs Medical Center, Nashville, Tennessee 372122; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Classen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Division of Infectious Diseases, Department of Medicine, LDS Hospital, Salt Lake City, Utah 841433"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Stratton","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Department of Medicine,1 and"},{"name":"<!--label omitted: 4-->Department of Pathology,4 Vanderbilt University School of Medicine, Nashville, Tennessee 37232;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen B.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Infectious Diseases, Department of Medicine,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.1975"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.1.53"},{"key":"e_1_3_2_4_2","unstructured":"Chapin-Robertson K. Edberg S. E. Measurement of antibiotics in human body fluids: techniques and significance Antibiotics in laboratory medicine 3rd ed. Lorian V. 1991 295 366 Williams and Wilkins Baltimore Md"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(96)80123-X"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.2.173"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.12.2574"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.396a"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.1.103"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440070049031"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.3.420"},{"key":"e_1_3_2_12_2","unstructured":"Kernodle D. S. D. C. Classen C. W. Stratton and A. B. Kaiser. Unpublished data."},{"key":"e_1_3_2_13_2","unstructured":"Kloos W. E. Jorgensen J. H. Staphylococci Manual of clinical microbiology 4th ed. Lennette E. H. Balows A. Hausler W. J. Jr. Shadomy H. J. 1985 143 153 American Society for Microbiology Washington D.C"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-7-1-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1994.tb06899.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.23.5.832-839.1986"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.3.759"},{"key":"e_1_3_2_18_2","unstructured":"National Committee for Clinical Laboratory Standards Approved standard M7A2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 1990 National Committee for Clinical Laboratory Standards Villanova Pa"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-33-1-121"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1086\/646432","article-title":"Methicillin-resistant Staphylococcus aureus in U.S. hospitals","volume":"13","author":"Panlilio A. L.","year":"1992","unstructured":"Panlilio A. L. Culver D. H. Gaynes R. P. Banerjee S. Henderson T. S. Tolson J. S. Martone W. J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals.Infect. Control Hosp. Epidemiol. 13 1992 582 586","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0940584"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-77-1-229"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-16-4-391"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Schaberg D. R. D. H. Culver and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91 (Suppl. 3B) : 72S\u201375S.","DOI":"10.1016\/0002-9343(91)90346-Y"},{"key":"e_1_3_2_25_2","first-page":"1862","article-title":"Is methicillin better than cloxacillin in serious infections caused by strong penicillinase-producing staphylococci (phage-type 94\/96)?","volume":"157","author":"Siboni A. H.","year":"1995","unstructured":"Siboni A. H. Jensen K. T. Rosdahl V. T. Gaub J. Is methicillin better than cloxacillin in serious infections caused by strong penicillinase-producing staphylococci (phage-type 94\/96)? Ugeskr. Laeg. 157 1995 1862 1864","journal-title":"Ugeskr. Laeg."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.12.1754"},{"key":"e_1_3_2_27_2","unstructured":"Smith P. B. Bacteriophage typing of Staphylococcus aureus The staphylococci. Cohn J. O. 1972 431 441 John Wiley and Sons New York N.Y"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.11.1869"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02009379"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.1.252-254.1992"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.2.440"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.36.1.219-222.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.36.1.219-222.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:40:21Z","timestamp":1722256821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.36.1.219-222.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1128\/JCM.36.1.219-222.1998"],"URL":"https:\/\/doi.org\/10.1128\/jcm.36.1.219-222.1998","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"1997-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-10-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}